EcoDrugPlus

Mitogen-Activated Protein Kinase Kinase Kinase 9

Ensembl ID : ENSPREG00000018522
Gene Symbol: MAP3K9
3 Cross references
193 Possible Orthologues:

Monoglyceride Lipase

Ensembl ID : ENSPREG00000012613
Gene Symbol: MGLL
3 Cross references
208 Possible Orthologues:

Motilin Receptor

Ensembl ID : ENSPREG00000014556
Gene Symbol: MLNR
3 Cross references
174 Possible Orthologues:

Mucosa-Associated Lymphoid Tissue Lymphoma Translocation Protein 1-Like

Ensembl ID : ENSPREG00000008046
Gene Symbol: LOC103469935
2 Cross references
195 Possible Orthologues:

Mucosal Pentraxin-Like

Ensembl ID : ENSPREG00000019722
Gene Symbol: LOC103478627
2 Cross references
353 Possible Orthologues:

Muscarinic Acetylcholine Receptor M5-Like

Ensembl ID : ENSPREG00000010510
Gene Symbol: LOC103457341
3 Cross references
189 Possible Orthologues:

Natriuretic Peptide Receptor 1

Ensembl ID : ENSPREG00000015890
Gene Symbol: NPR1
3 Cross references
190 Possible Orthologues:

Natriuretic Peptide Receptor 2

Ensembl ID : ENSPREG00000015307
Gene Symbol: NPR2
3 Cross references
191 Possible Orthologues:

Natriuretic Peptide Receptor 3

Ensembl ID : ENSPREG00000011857
Gene Symbol: NPR3
3 Cross references
207 Possible Orthologues:

Neurogenic Locus Notch Homolog Protein 1-Like

Ensembl ID : ENSPREG00000001810
Gene Symbol: LOC103473440
3 Cross references
196 Possible Orthologues:

Neurogenic Locus Notch Homolog Protein 2-Like

Ensembl ID : ENSPREG00000006129
Gene Symbol: LOC103468742
3 Cross references
197 Possible Orthologues:

Neuromedin-K Receptor-Like

Ensembl ID : ENSPREG00000005349
Gene Symbol: LOC103466251
4 Cross references
218 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).